Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page .
Argus Research analyst John Eade upgraded Moderna Inc (NASDAQ: MRNA ) from Hold to Buy and announced a $180 price target. Moderna closed at $142.77 on Thursday. See how other analysts view this stock. Northland Capital Markets analyst Jeff Grampp upgraded Evolution Petroleum Corporation (AMEX: EPM ) from Market Perform to Outperform and announced a $4 price target. Evolution Petroleum shares closed at $3.58 on Thursday. See how other analysts view this stock . CIBC analyst Robert Catellier upgraded Enbridge (TSX: ENB ) from Neutral to Outperformer and raised the price target from C$77 to C$78. See how other analysts view this stock .Considering buying MRNA stock? Here’s what analysts think:
Photo via Shutterstock
Trending Market News and Data brought to you by Benzinga APIs© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here .
Posted In: Markets Trading Ideas News Analyst Ratings Upgrades Top Upgrades